Stock: Medtronic (US broad), ISIN: US5850551061

Last Price 128.54 Max Price 131.20
Min Price 96.29 1 Year return 13.30


(US5850551061)/ MDT

Past year was a negative year for Medtronic investors

The period between December 2015 and December 2016 was a bad period for the investors. The stock lost almost 5 percent. Over the past 5 years the stock rose a massive 98,24 percent. Medtronic's revenues between 2011 and 2015 were very fluctuating and moved between 16,18 billion dollars and 20,26 billion dollars. Medtronic's net results between 2011 and 2015 were relatively steady and moved between 3,1 billion dollars and 2,68 billion dollars.

Medtronic has located her head office Minneapolis. The company mostly operates in the health care eq. & services sector. Medtronic is leaded by CEO Omar Ishrak The CFO of Medtronic the company is Gary L. Ellis. The global health care companies gained around 102 percent worldwide over the last 10 years. Since 2011 the sector is 64 percent higher and over the past year plus 102 percent.

The American company paid out dividends in the past 5 years. Over the past 5 years the stock delivered an average dividend return of 5,25 percent.

Medtronic' balance mostly financed with equity

As per the end of 2015 the American company's balance sheet equaled 106,69 billion dollars. 53,46 billion dollars (50,11 percent of the total balance sheet) was financed by debt. At the end of 2016 the American company was traded with a price/earnings-ratio of around 24. So investors paid 24 times the company's 2015's EPS. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 107,42 billion dollars. At the end of 2015 around 1,42 billion stocks were listed.

All of Medtronic's annual reports are stored here. More information about Medtronic can be found it's website. .